S
Shin-ichi Muramatsu
Researcher at Jichi Medical University
Publications - 189
Citations - 6916
Shin-ichi Muramatsu is an academic researcher from Jichi Medical University. The author has contributed to research in topics: Dopamine & Adeno-associated virus. The author has an hindex of 40, co-authored 165 publications receiving 5972 citations. Previous affiliations of Shin-ichi Muramatsu include Meijo University & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Electrophysiological study of dyskinesia produced by microinjection of picrotoxin into the striatum of the rat.
TL;DR: The neuronal mechanism of dyskinesia of the contralateral forelimb produced by microinjection of picrotoxin into the caudoputaminal unit (CPU) was analyzed electrophysiologically and it is proposed that the primary origin of the dyskinisia is the CPU and that the inhibitory CPU efferent, as well as the nigrothalamic, pathway plays a basic role in the manifestation of the Dyskineia.
Journal ArticleDOI
Overexpression of Shati/Nat8l, an N-acetyltransferase, in the nucleus accumbens attenuates the response to methamphetamine via activation of group II mGluRs in mice
Yoshiaki Miyamoto,Yudai Ishikawa,Noriyuki Iegaki,Kazuyuki Sumi,Kequan Fu,Keiji Sato,Yoko Furukawa-Hibi,Shin-ichi Muramatsu,Toshitaka Nabeshima,Kyosuke Uno,Atsumi Nitta +10 more
TL;DR: Results indicate that Shati/Nat8l in the NAc, but not in the dS, plays an important suppressive role in the behavioral responses to METH by controlling the dopaminergic system via activation of group II mGluRs.
Journal ArticleDOI
Regulation of the dopaminergic system in a murine model of aromatic l-amino acid decarboxylase deficiency
Ni-Chung Lee,Yih-Dar Shieh,Yin-Hsiu Chien,Kai-Yuan Tzen,I-Shing Yu,Pin-Wen Chen,Min-Hsiu Hu,Meng-kai Hu,Shin-ichi Muramatsu,Hiroshi Ichinose,Wuh-Liang Hwu +10 more
TL;DR: An AADC deficient mouse model is generated, in which compensatory regulation allowed the mice to survive to adulthood and will be useful both for developing gene therapies for A ADC deficiency and for designing treatments for diseases associated with neurotransmitter deficiency.
Journal ArticleDOI
Preclinical substantia nigra dysfunction in rapid eye movement sleep behaviour disorder.
Masayuki Miyamoto,Tomoyuki Miyamoto,Masaoki Iwanami,Shin-ichi Muramatsu,Sayaka Asari,Imaharu Nakano,Koichi Hirata +6 more
TL;DR: Pathological hyperechogenic alterations in the SN in patients with iRBD may suggest the existence of preclinical SN dysfunction as determined by FMT-PET.
Journal ArticleDOI
TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets
Kunihiko Araki,Amane Araki,Daiyu Honda,Takako Izumoto,Atsushi Hashizume,Yasuhiro Hijikata,Shinichiro Yamada,Yohei Iguchi,Akitoshi Hara,Kazuhiro Ikumi,Kaori Kawai,Shinsuke Ishigaki,Yoko Nakamichi,Shin Tsunekawa,Yusuke Seino,Akiko Yamamoto,Yasunori Takayama,Shihomi Hidaka,Makoto Tominaga,Mica Ohara-Imaizumi,Atsushi Suzuki,Hiroshi Ishiguro,Atsushi Enomoto,Mari Yoshida,Hiroshi Arima,Shin-ichi Muramatsu,Gen Sobue,Masahisa Katsuno +27 more
TL;DR: The findings suggest that TDP-43 regulates cellular exocytosis mediated by L-type voltage-dependent calcium channels and thus plays an important role in the early phase of insulin secretion by pancreatic islets, and is implicated in not only the selective loss of motor neurons but also in glucose intolerance due to impaired insulin secretion at an early stage of ALS.